EGF and Alzheimer disease: In addition, the pattern of protein changes observed in the present study was not the same as in Ray et al. More specifically, in the training set described in the study by Ray et al [10], plasma z- levels of PDGF-BB, EGF and MIP-1δ were seen to be reduced in AD cases.